Clinical Trial Update: Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating fecal microbiota transplantation in metastatic non-small cell lung cancer and advanced melanoma, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Non Small Cell Lung Cancer Metastatic, Advanced Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING